Preconditioning the diabetic heart: The importance of Akt phosphorylation

Diabetes

Volumn 54, Issue 8, 2005, Pages 2360-2364

  Tsang, Andrew ^a   Hausenloy, Derek J ^a   Mocanu, Mihaela M ^a   Carr, Richard D ^b   Yellon, Derek M ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GLUCOSE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; HEART INFARCTION SIZE; HEART PROTECTION; HYPERGLYCEMIA; ISCHEMIC HEART DISEASE; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR;

EID: 23644447741     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.8.2360     Document Type: Article

References (35)

1. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349:1498-1504, 1997
2. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: the Framingham study. Circulation 59:8-13, 1979
3. Abbud ZA, Shindler DM, Wilson AC, Kostis JB: Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: a statewide study: Myocardial Infarction Data Acquisition System Study Group. Am Heart J 130:51-58, 1995
4. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
5. Will JC, Casper M: The contribution of diabetes to early deaths from ischemic heart disease: US gender and racial comparisons. Am J Public Health 86:576-579, 1996
6. Smith JW, Marcus FI, Serokman R: Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol 54:718-721, 1984
7. Abbott RD, Donahue RP, Kannel WB, Wilson PW: The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham Study. JAMA 260:3456-3460, 1988
8. Herlitz J, Wognsen GB, Emanuelsson H, Haglid M, Karlson BW, Karlsson T, Albertsson P, Westberg S: Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care 19:698-703, 1996
9. Paulson DJ: The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res 34:104-112, 1997
10. Liu Y, Thornton JD, Cohen MV, Downey JM, Schaffer SW: Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation 88:1273-1278, 1993
11. Tatsumi T, Matoba S, Kobara M, Keira N, Kawahara A, Tsuruyama K, Tanaka T, Katamura M, Nakagawa C, Ohta B, Yamahara Y, Asayama J, Nakagawa M: Energy metabolism after ischemic preconditioning in streptozotocin-induced diabetic rat hearts. J Am Coll Cardiol 31:707-715, 1998
12. Ravingerova T, Stetka R, Pancza D, Ulicna O, Ziegelhoffer A, Styk J: Susceptibility to ischemia-induced arrhythmias and the effect of preconditioning in the diabetic rat heart. Physiol Res 49:607-616, 2000
13. Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC: Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol 278:H1218-H1224, 2000
14. Nieszner E, Posa I, Kocsis E, Pogatsa G, Preda I, Koltai MZ: Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits. Exp Clin Endocrinol Diabetes 110:212-218, 2002
15. Tosaki A, Pali T, Droy-Lefaix MT: Effects of Ginkgo biloba extract and preconditioning on the diabetic rat myocardium. Diabetologia 39:1255-1262, 1996
16. Tosaki A, Engelman DT, Engelman RM, Das DK: The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res 31:526-536, 1996
17. Ravingerova T, Stetka R, Volkovova K, Pancza D, Dzurba A, Ziegelhoffer A, Styk J: Acute diabetes modulates response to ischemia in isolated rat heart. Mol Cell Biochem, 210:143-151, 2000
18. del Valle HF, Lascano EC, Negroni JA, Crottogini AJ: Absence of ischemic preconditioning protection in diabetic sheep hearts: role of sarcolemmal KATP channel dysfunction. Mol Cell Biochem 249:21-30, 2003
19. del Valle HF, Lascano EC, Negroni JA: Ischemic preconditioning protection against stunning in conscious diabetic sheep: role of glucose, insulin, sarcolemmal and mitochondrial KATP channels. Cardiovasc Res 55:642-659, 2002
20. Tong H, Chen W, Steenbergen C, Murphy E: Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res 87:309-315, 2000
21. Mocanu MM, Bell RM, Yellon DM: PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol 34:661-668, 2002
22. Desrois M, Sidell RJ, Gauguier D, King LM, Radda GK, Clarke K: Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart. Cardiovasc Res 61:288-296, 2004
23. Huisamen B: Protein kinase B in the diabetic heart. Mol Cell Biochem 249:31-38, 2003
24. Steiler TL, Galuska D, Leng Y, Chibalin AV, Gilbert M, Zierath JR: Effect of hyperglycemia on signal transduction in skeletal muscle from diabetic Goto-Kakizaki rats. Endocrinology 144:5259-5267, 2003
25. Goto Y, Kakizaki M, Masaki N: Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med 119:85-90, 1976
26. Goto Y, Suzuki K, Ono T, Sasaki M, Toyota T: Development of diabetes in the non-obese NIDDM rat (GK rat). Adv Exp Med Biol 246:29-31, 1988
27. Hausenloy DJ, Duchen MR, Yellon DM: Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res 60:617-625, 2003
28. Kondo T, Kahn CR: Altered insulin signaling in retinal tissue in diabetic states. J Biol Chem 279:37997-38006, 2004
29. El Remessy AB, Bartoli M, Platt DH, Fulton D, Caldwell RB: Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. J Cell Sci 118:243-252, 2005
30. Ceriello A, Quagharo L, D'Amico M, Di Filippo C, Marfella R, Nappo F, Berrino L, Rossi F, Giugliano D: Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51:1076-1082, 2002
31. Cheta D: Animal models of type I (insulin-dependent) diabetes mellitus. J Pediatr Endocrinol Metab 11:11-19, 1998
32. Janssen U, Phillips AO, Floege J: Rodent models of nephropathy associated with type II diabetes. J Nephrol 12:159-172, 1999
33. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431, 1998
34. Kristiansen SB, Lofgren B, Stottrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT, Botker HE, Flyvbjerg A: Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia 47:1716-1721, 2004
35. Hadour G, Ferrera R, Sebbag L, Forrat R, Delaye J, de Lorgeril M: Improved myocardial tolerance to ischaemia in the diabetic rabbit. J Mol Cell Cardiol 30:1869-1875, 1998